We Can Do Better Fighting the Opioid Crisis

According to a recent report from the Centers for Disease Control and Prevention, New York has seen a decline in overdose deaths for the first time in years, but we lag behind neighboring states in how quickly we are mitigating them. Opioid overdose study (A.7746) - directs the commissioner of the D...

Full description

Saved in:
Bibliographic Details
Published inThe Business Journal - Central New York Vol. 39; no. 23; p. 17
Main Author Barclay, Will
Format Trade Publication Article
LanguageEnglish
Published Syracuse Central New York Business Journal 10.06.2024
Subjects
Controlled substances
Drug overdose
Narcotics
New York
United States > US
Online AccessGet full text

Cover

More Information
Summary:According to a recent report from the Centers for Disease Control and Prevention, New York has seen a decline in overdose deaths for the first time in years, but we lag behind neighboring states in how quickly we are mitigating them. Opioid overdose study (A.7746) - directs the commissioner of the Department of Health to conduct a study to identify, analyze, report, and medically combat new or previously unseen opioid compounds found in overdose patients; Long-term rehabilitation alternative (A.4146) - creates a long-term rehabilitation alternative for certain opioid offenders in lieu of prison; Allow judges more discretion to hold drug dealers (A.5992) - gives judges more discretion when issuing securing orders for a defendant after taking into account their flight risk, the seriousness of the crime, and whether they are a danger to the community. Authorizes the revocation of recognizance or bail for felony drug offenders who refuse to participate in court-ordered drug treatment or for failing to appear before court; Create the "Death by Dealer" statute (A.7985) - establishes the crime of criminal sale of a controlled substance resulting in death, a class A-1 felony; and Classify xylazine as Schedule I controlled substance (A.8130) - classifies xylazine as a Schedule I controlled substance and creates penalties for the criminal sale and possession of xylazine or preparations, compounds, mixtures, or substances containing the drug.